BioNTech SE (BNTX) Change in Cash (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Change in Cash data on file, last reported at -$2.8 billion in Q4 2025.

• In Q4 2025, Change in Cash fell 2045.25% year-over-year to -$2.8 billion; the TTM figure through Dec 2025 stood at -$2.5 billion (down 16.5% YoY), while the FY2025 annual figure was -$2.3 billion, down 13.77% from the prior year.
• Change in Cash eased to -$2.8 billion in Q4 2025, from -$182.5 million in the prior quarter.
• Across five years, Change in Cash topped out at $5.0 billion in Q1 2022 and bottomed at -$2.9 billion in Q1 2024.
• A 5-year average of $356.8 million and a median of $52.7 million in 2021 frame the typical range for Change in Cash.
• Annual changes were most pronounced in 2022 — Change in Cash surged 1194599910.37% — and 2025, when it sank 2045.25%.
• Year by year, Change in Cash stood at -$818.4 in 2021, then surged by 75234909.21% to $615.7 million in 2022, then plunged by 424.52% to -$2.0 billion in 2023, then jumped by 107.28% to $145.4 million in 2024, then sank by 2045.25% to -$2.8 billion in 2025.
• The last three Change in Cash figures came in at -$2.8 billion (Q4 2025), -$182.5 million (Q3 2025), and $77.9 million (Q2 2025), per Business Quant data.

Peer Comparison